1. Home
  2. NNVC vs TELA Comparison

NNVC vs TELA Comparison

Compare NNVC & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NNVC

NanoViricides Inc.

N/A

Current Price

$1.43

Market Cap

33.7M

Sector

Health Care

ML Signal

N/A

Logo TELA Bio Inc.

TELA

TELA Bio Inc.

N/A

Current Price

$0.85

Market Cap

31.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NNVC
TELA
Founded
2005
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.7M
31.4M
IPO Year
2008
2019

Fundamental Metrics

Financial Performance
Metric
NNVC
TELA
Price
$1.43
$0.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
★ $6.00
$1.90
AVG Volume (30 Days)
★ 157.6K
94.4K
Earning Date
11-24-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
34.92
★ 37.59
EPS
N/A
N/A
Revenue
N/A
★ $80,275,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$8.58
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 15.84
52 Week Low
$0.85
$0.50
52 Week High
$1.93
$1.50

Technical Indicators

Market Signals
Indicator
NNVC
TELA
Relative Strength Index (RSI) 53.39 40.92
Support Level $1.23 $0.61
Resistance Level $1.49 $0.97
Average True Range (ATR) 0.10 0.10
MACD -0.01 -0.01
Stochastic Oscillator 59.26 19.74

Price Performance

Historical Comparison
NNVC
TELA

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company is engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific antiviral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing. The Company's platform is based on host-mimicry and thereby has uniquely enabled the development of broad-spectrum antiviral drugs that the viruses would be unable to escape, a critical unmet need in antiviral therapeutics.

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

Share on Social Networks: